NCT06654622View on ClinicalTrials.gov

Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

June 18, 2026

Study Completion Date

June 18, 2026

Conditions

Colo-rectal CancerColorectal Cancer Recurrent

Trial Locations (1)

91010

RECRUITING

City of Hope Medical Center, Duarte

All Listed Sponsors

lead

City of Hope Medical Center

OTHER